HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California’s Toxic-Free Cosmetics Act Amended, Pushed Closer To Governor’s Desk

Executive Summary

On 20 August, the Senate Appropriations Committee approved an amended version of the proposed Toxic-Free Cosmetics Act, which passed the Assembly in June. Changes to the bill would alleviate burdens on California’s Department of Public Health and reduce penalties for violators.

You may also be interested in...



Did California Catch Brazilian Blowout Napping? Formaldehyde Must Be Out Of Hair Smoothers By 2025

California-based Brazilian Blowout appears not to have opposed the Toxic-Free Cosmetics Act, signed into law in the Golden State at the end of September, which will ban a key ingredient in its professional hair-smoothing systems beginning 1 January 2025. The company remains oddly quiet about the legislation, which was backed by NGOs, public health advocates and other cosmetic industry reps.

California Will Prohibit Use Of Some Cosmetic Ingredients Banned In Europe Beginning in 2025

Starting in 2025, use of selected preservatives, phthalates and other ingredients already banned in Europe will be prohibited in cosmetics sold in California.

California Fragrance Disclosure Bill Headed For Assembly Vote With Time Running Out

The proposed Cosmetic Fragrance and Flavor Ingredient Right to Know Act faces no opposition in its current form, but must pass California’s Assembly and get the Senate’s concurrence before 1 September.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150408

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel